1989
DOI: 10.3109/00016488909127482
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Arginine-vasopressin and its Analogues upon the Endocochlear Potential in the Guinea Pig

Abstract: The effect of arginine-vasopressin (AVP) and its analogues upon the endocochlear potential (EP) was examined in the guinea pig. AVP decreased the EP reversibly and dose-dependently like lysin-vasopressin (LVP). V1 antagonist failed to block the effect of AVP upon the EP. V2 agonist reversibly decreased the EP like AVP. The results suggest that V2 receptors mediate the action of vasopressin on the EP.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1991
1991
2009
2009

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 19 publications
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…In addition, it was reported previously that V 2 -R mediated the action of VP on the endocochlear potential [20]. Thus it was hypothesized in the present study that the administration of OPC-31260 before VP injection may reduce the enlargement of the intrastrial space caused by VP via the blockade of water transport from the perilymph to the the basolateral (perylymph) side of the basal cells, in which AQP2 is expressed.…”
Section: Discussionmentioning
confidence: 93%
“…In addition, it was reported previously that V 2 -R mediated the action of VP on the endocochlear potential [20]. Thus it was hypothesized in the present study that the administration of OPC-31260 before VP injection may reduce the enlargement of the intrastrial space caused by VP via the blockade of water transport from the perilymph to the the basolateral (perylymph) side of the basal cells, in which AQP2 is expressed.…”
Section: Discussionmentioning
confidence: 93%
“…In the guinea pig, the systemic administration of AVP decreased the endocochlear potential, an effect that was reversed by V2 receptor but not by V1 receptor antagonists [42], and elicited the development of an endolymphatic hydrops [28]. In the same species, the injection of cholera toxin, a compound that increases the intracellular concentration of cAMP, AVP V2 receptors second messenger also induced an endolymphatic hydrops [37].…”
Section: Atp and Acoustic Traumamentioning
confidence: 95%